Kirsten Canté-Barrett

10PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyTumour immunologyMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 19, 2025
RAG1 lentiviral gene therapy restores T-cell development of RAG1-SCID patient cells in artificial thymic organoids.

Xiaolin Meng, Janine E Melsen, Rosalie van der Holst

|Jun 25, 2024
Utilizing epigenetic regulators to improve HSC-based lentiviral gene therapy.

Parisa Tajer, Emin Onur Karakaslar, Kirsten Canté-Barrett

|Nov 11, 2022
Single-cell immune profiling reveals thymus-seeding populations, T cell commitment, and multilineage development in the human thymus.

Martijn Cordes, Kirsten Canté-Barrett, Erik B van den Akker

|Nov 11, 2022
IL3 Has a Detrimental Effect on Hematopoietic Stem Cell Self-Renewal in Transplantation Settings.

Parisa Tajer, Kirsten Canté-Barrett, Brigitta A E Naber

|Jan 11, 2022
Stem Cell-Based Disease Models for Inborn Errors of Immunity.

Aline Zbinden, Kirsten Canté-Barrett, Karin Pike-Overzet

|Oct 18, 2021
T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.

Valentina Cordo', Jordy C G van der Zwet, Kirsten Canté-Barrett

Pageof 2